The L-type calcium channel, composed of the α1C, α1D, α1F, and α1S subunits, plays a pivotal role in cellular calcium homeostasis and excitation-contraction coupling in cardiac and smooth muscle cells. These channels are voltage-gated and regulate the influx of calcium ions into the cell in response to membrane depolarization, thereby influencing various physiological processes such as muscle contraction, neurotransmitter release, and gene expression. The α1C subunit, in particular, is predominantly expressed in cardiac myocytes and is essential for cardiac excitation-contraction coupling, contributing to the initiation and propagation of action potentials in the heart.
Activation of the L-type calcium channel involves intricate mechanisms primarily mediated by changes in membrane potential and intracellular signaling cascades. Upon membrane depolarization, voltage sensors within the channel undergo conformational changes, leading to the opening of the channel pore and subsequent influx of calcium ions. Additionally, various second messenger systems, including cyclic adenosine monophosphate (cAMP) and protein kinase C (PKC), modulate the activity of L-type calcium channels through phosphorylation events. Activation of adrenergic receptors, for instance, stimulates the production of cAMP, which in turn activates protein kinase A (PKA), leading to phosphorylation of the L-type calcium channel and enhancement of channel activity. Similarly, activation of PKC by various stimuli promotes phosphorylation of specific residues within the channel protein, further augmenting calcium influx. Moreover, intracellular calcium ions can exert positive feedback on L-type calcium channels, enhancing their activity through calcium-induced calcium release mechanisms. Overall, the activation of L-type calcium channels represents a coordinated interplay of membrane depolarization and intracellular signaling pathways, culminating in the regulation of cellular calcium dynamics and physiological processes essential for cardiac and smooth muscle function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Known to increase calcium channel activity by stabilizing the open state of the channel, potentially affecting L-type Ca++ channels. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
While it is a blocker, under specific circumstances, it may have a secondary effect on channel dynamics. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Known as a calcium channel blocker, but it can influence the channel's activity in a complex manner. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
Known to enhance calcium channel opening, potentially affecting L-type channels. | ||||||
Gabapentin | 60142-96-3 | sc-201481 sc-201481A sc-201481B | 20 mg 100 mg 1 g | $53.00 $94.00 $135.00 | 7 | |
Primarily affects GABAergic systems but may have indirect effects on calcium channel activity. | ||||||
L-phenylephrine | 59-42-7 | sc-295315 sc-295315A | 5 g 25 g | $181.00 $492.00 | 2 | |
A sympathomimetic that can influence calcium channel activity indirectly through adrenergic pathways. | ||||||